This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Conditions:   Carcinoma, Non-Small-Cell Lung;   Head and Neck Neoplasms
Interventions:   Drug: BI 754111;   Drug: [89Zr]Zr-BI 754111;   Drug: BI 754091
Sponsor:   Boehringer Ingelheim
Not yet recruiting

https://ift.tt/2BspW00